Keijiro Numa

Takatsuki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Tip-in underwater endoscopic mucosal resection for a sessile lesion at a poorly visualized location.

Tip-in underwater endoscopic mucosal resection for a sessile lesion at a poorly visualized location.

Journal: Endoscopy

Published: January 20, 2026

A Clinical Prediction Model for Early Colectomy in Patients With Severe Ulcerative Colitis Treated With Tacrolimus.

A Clinical Prediction Model for Early Colectomy in Patients With Severe Ulcerative Colitis Treated With Tacrolimus.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: August 15, 2025

Real-world effectiveness and safety of carotegrast methyl in patients with ulcerative colitis: a multicenter retrospective cohort study.

Real-world effectiveness and safety of carotegrast methyl in patients with ulcerative colitis: a multicenter retrospective cohort study.

Journal: Intestinal research

Published: April 25, 2025

Depressed lesion detected during surveillance colonoscopy in a patient with ulcerative colitis.

Depressed lesion detected during surveillance colonoscopy in a patient with ulcerative colitis.

Journal: Intestinal research

Published: April 02, 2025

Ulcerative Lesion of the Ileocecal Region in a Patient With Immunodeficiency.

Ulcerative Lesion of the Ileocecal Region in a Patient With Immunodeficiency.

Journal: Journal of gastroenterology and hepatology

Published: March 09, 2025

Correction: Tatsumi et al. Biomarkers for Monitoring of Changes in Disease Activity in Ulcerative Colitis. J. Clin. Med. 2023, 12, 7165.

Correction: Tatsumi et al. Biomarkers for Monitoring of Changes in Disease Activity in Ulcerative Colitis. J. Clin. Med. 2023, 12, 7165.

Journal: Journal of clinical medicine

Published: June 09, 2024

C-reactive protein-to-lymphocyte ratio is a novel biomarker for predicting the long-term efficacy of ustekinumab treatment in ulcerative colitis.

C-reactive protein-to-lymphocyte ratio is a novel biomarker for predicting the long-term efficacy of ustekinumab treatment in ulcerative colitis.

Journal: PloS one

Published: January 15, 2024

Comparing the Effects of Anti-TNF Agent and Ustekinumab on Small Bowel Inflammation in Crohn's Disease: Inverse Probability Weighting With Stabilized Weights of Propensity Scores.

Comparing the Effects of Anti-TNF Agent and Ustekinumab on Small Bowel Inflammation in Crohn's Disease: Inverse Probability Weighting With Stabilized Weights of Propensity Scores.

Journal: Crohn's & colitis 360

Published: November 21, 2023

Biomarkers for Monitoring of Changes in Disease Activity in Ulcerative Colitis.

Biomarkers for Monitoring of Changes in Disease Activity in Ulcerative Colitis.

Journal: Journal of clinical medicine

Published: September 29, 2023

Efficacy of Switching to Adalimumab for Maintenance of Remission Following Induction Therapy with Tacrolimus in Patients with Ulcerative Colitis.

Efficacy of Switching to Adalimumab for Maintenance of Remission Following Induction Therapy with Tacrolimus in Patients with Ulcerative Colitis.

Journal: Journal of clinical medicine

Published: September 25, 2023

Relationship between Chemotherapy-Induced Diarrhea and Intestinal Microbiome Composition.

Relationship between Chemotherapy-Induced Diarrhea and Intestinal Microbiome Composition.

Journal: Digestion

Published: August 10, 2022

Serum IL-13 Predicts Response to Golimumab in Bio-Naïve Ulcerative Colitis.

Serum IL-13 Predicts Response to Golimumab in Bio-Naïve Ulcerative Colitis.

Journal: Journal of clinical medicine

Published: July 15, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026